41P Impact of HER2-low and HER2-zero Status on Metastatic Hormonal Receptor-Positive Breast Cancer Patients Treated with First-Line Aromatase Inhibitors, with or Without CDK4/6 Inhibitors: A Multicenter Retrospective Analysis
Annals of Oncology（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要